Stock data
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST) reported net income of -US$63.06M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$62.14M | -US$63.06M | — |
| 2024 | — | — | -US$42.10M | -US$41.52M | — |
| 2023 | — | — | -US$61.10M | -US$59.69M | — |
| 2022 | — | — | -US$59.64M | -US$58.39M | — |
| 2021 | — | — | -US$43.07M | -US$42.85M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.56M | -US$28.61M | — |
| 2026-03-31 | US$0.24M | -US$26.07M | — |
| 2025-12-31 | — | -US$17.41M | — |
| 2025-09-30 | — | -US$11.92M | — |
| 2025-06-30 | US$0.00M | -US$12.97M | — |
| 2025-03-31 | US$0.00M | -US$20.76M | — |
| 2024-12-31 | — | -US$12.36M | — |
| 2024-09-30 | — | -US$9.44M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.